An artificial heart device tested in Louisville, Ky., will soon be available to patients who have no other treatment options.
The artificial heart has only been tested in 14 men. Two died from the operation and another never regained consciousness.
The rest survived only an average of five months, with one exception. A Western Kentucky man lived 17 months.
The Food and Drug Administration says the device's maker can sell up to 4,000 of them a year.
A FDA spokeswoman says the number of devices likely to be implanted will be between 25 and 50 a year.
Half the implants were done at Jewish Hospital in Louisville, Ky.